Sign in

CIK 0001359931

  • Non-accelerated filer
  • Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
204580525
Phone
+1 646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
  1. 4 Open-market sale 10% owner sold 200 shares at $25.19 ($5,038)
  2. 4 Open-market sale 10% owner sold 2,248 shares at an average $25.10 ($56,433)
  3. 4 Open-market sale 10% owner sold 3,833 shares at an average $26.33 ($100,910)
  4. 4 Open-market sale 10% owner sold 25,935 shares at an average $30.48 ($790,612)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market sale 10% owner sold 2,343 shares at an average $26.53 ($62,169)
  8. 4 Open-market sale 10% owner sold 1,595 shares at an average $26.71 ($42,598)
  9. 4 Open-market sale 10% owner sold 4,330 shares at an average $26.79 ($116,010)
  10. 4 Open-market sale 10% owner sold 4,804 shares at an average $27.28 ($131,077)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4/A Grant or award Director acquired 26,500 shares (grant or award)
  16. 4 Derivatives Options or other derivatives
  17. 4/A Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4/A Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 10 of 20 · 382 filings